InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Global Cell and Gene Therapy Bioassay Services Market- by Type of Therapy (Cell Therapy and Gene Therapy), Therapeutic Area (Oncological, Infectious, Autoimmune, Rare/Genetic, Cardiovascular, Metabolic, Blood, Neurological, Ophthalmic Disorders and Other Therapeutic Areas), Scale of Operation (Discovery, Preclinical and Clinical), Trends, Industry Competition Analysis, Revenue and Forecast To 2034.”
According to the latest research by InsightAce Analytic, the global Cell and Gene Therapy Bioassay Services Market Size is estimated to grow at a 25.0% CAGR during the forecast period for 2025-2034.
Request For Free Sample Pages:
https://www.insightaceanalytic.com/request-sample/1208
Cell and gene therapies involve the extraction of proteins, cells, or genetic material from a patient or donor, followed by modification to enable highly targeted or personalized treatment.
Numerous factors, such as the growing need for enhanced medical treatments, the rising incidence of cancer and other chronic diseases, and advances in genomics technology methodologies, are primarily driving market expansion. Increasing demand for personalized medicines and increased government investment in the R&D of new cell and gene therapies are expected to drive demand for bioassay services over the forecast period.
North America is anticipated to be the major contributor to the Cell and Gene Therapy Bioassay Services Market because of the increasing number of cell and gene therapy product launches and increased R&D activity in biopharma businesses to create cell and gene treatments. In addition, the Asia Pacific regional market is expected to register significant growth because of the high frequency of chronic diseases and genetic abnormalities, the growing older population, patients’ increasing need for tailored treatments, and improved technological advances.
Curious about this latest version of the report? Obtain Report Details @ https://www.insightaceanalytic.com/enquiry-before-buying/1208
Major market players operating in the Cell and Gene Therapy Bioassay Services Market include AnaBioTec (Belgium), CCRM (Canada), Nexelis (Canada), Pacific BioLabs (US), PPD Laboratories (North Carolina), Intertek Pharmaceutical Services (UK), Lonza (Switzerland), Porton Biopharma Ltd (UK), WuXi Advanced Therapies (US), Avomeen (US), Charles River Laboratories (US), Absorption Systems (US), BioAgilytix Labs (US), Catalent, Inc (US), Svar Life Science AB (Sweden), and others.
Recent collaborations and agreements in the market:
- In December 2021, CCRM Enterprises Inc., the company’s venture capital arm, purchased Mediphage Bioceuticals, Inc. The investment by CCRM Enterprises will be utilized to fund the development and operation of the technology, as well as access to CCRM’s scientific and industrial knowledge. Mediphage is concentrating on developing a non-viral gene therapy platform that will pave the way for individualized genetic treatment that is both safe and effective while also resolving many of the shortcomings of current viral vector-based technologies.
- In April 2021, AavantiBio (US), a gene therapy firm, and Catalent (US), a drug, cell, and gene therapy supplier, collaborated to support the development and manufacture of AavantiBio’s gene treatments.
Get Specific Chapter/Information From The Report: @
https://www.insightaceanalytic.com/customisation/1208
Market Segments
Global Cell and Gene Therapy Bioassay Services Market, by Type of Therapy, 2025-2034 (Value US$ Mn)
- Cell Therapy
- Gene Therapy
Global Cell and Gene Therapy Bioassay Services Market, by Therapeutic Area, 2025-2034 (Value US$ Mn)
- Oncological
- Infectious
- Autoimmune
- Rare / Genetic
- Cardiovascular
- Metabolic
- Blood
- Neurological
- Ophthalmic Disorders
- Other Therapeutic Areas
Global Cell and Gene Therapy Bioassay Services Market, by Scale of Operation, 2025-2034 (Value US$ Mn)
- Discovery
- Preclinical
- Clinical
Global Cell and Gene Therapy Bioassay Services Market, by Region, 2025-2034 (Value US$ Mn)
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
North America Cell and Gene Therapy Bioassay Services Market, by Country, 2025-2034 (Value US$ Mn)
- S.
- Canada
Europe Cell and Gene Therapy Bioassay Services Market, by Country, 2025-2034 (Value US$ Mn)
- Germany
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific Cell and Gene Therapy Bioassay Services Market, by Country, 2025-2034 (Value US$ Mn)
- India
- China
- Japan
- South Korea
- Australia & New Zealand
Latin America Cell and Gene Therapy Bioassay Services Market, by Country, 2025-2034 (Value US$ Mn)
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa Cell and Gene Therapy Bioassay Services Market, by Country, 2025-2034 (Value US$ Mn)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Get More Information :
https://www.insightaceanalytic.com/report/global-cell-and-gene-therapy-bioassay-services-market/1208
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.
Contact Us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace
